Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Arthrosc Tech ; 13(5): 102954, 2024 May.
Article in English | MEDLINE | ID: mdl-38835470

ABSTRACT

Meniscus allograft transplantation (MAT) is a technically challenging procedure. Bone plugs, slot techniques, and all-soft-tissue fixation techniques have been described in the past. Each technique comes with advantages and disadvantages. Native menisci have circumferential collagen fibers to help resist hoop stress during loading cycles. Although hoop stress resistance is a known function of the menisci, its recreation in MAT has only been targeted indirectly through anatomic root placement. The authors describe the use of a high-tensile suture tape (i.e. InternalBrace) to promote centralization by directly mitigating hoop stresses through recreation of peripheral meniscus tensioning in MAT.

2.
J Surg Orthop Adv ; 33(1): 26-28, 2024.
Article in English | MEDLINE | ID: mdl-38815074

ABSTRACT

When a surgical needle is lost, the protocol is to explore the surgical field and to obtain a plain radiograph if the needle cannot be located. The size of the needle that can be detected with imaging is debated. Plain-film radiographs, C-arm, and mini C-arm fluoroscopy imaging was obtained of a cadaveric hand with retained needle of varying lengths (suture sizes 4-0 - 10-0). The authors performed analyses to determine the sensitivity and specificity of the imaging modalities. There were no differences in diagnostic area under the receiver operating characteristic curve between the three modalities. For plain film, optimal cutoff for needle size was 5.2 mm (sensitivity 0.87, specificity 0.75), for C-arm 6.8 mm (sensitivity 0.84, specificity 0.87), and for mini C-arm 5.9 mm (sensitivity 0.82, specificity 0.86). In the hand, the use of C-arm fluoroscopy is as sensitive as plain-film radiography at detecting retained needles greater than 5.9 mm. (Journal of Surgical Orthopaedic Advances 33(1):026-028, 2024).


Subject(s)
Foreign Bodies , Hand , Needles , Humans , Fluoroscopy , Foreign Bodies/diagnostic imaging , Hand/diagnostic imaging , Cadaver , Sensitivity and Specificity , Radiography/methods
3.
Article in English | MEDLINE | ID: mdl-38364177

ABSTRACT

INTRODUCTION: This study aims to characterize radiographic features and fracture characteristics in femoral shaft fractures with associated femoral neck fractures, with the goal of establishing predictive indicators for the presence of ipsilateral femoral neck fractures (IFNFs). METHODS: A retrospective cohort was collected from the electronic medical record of three level I trauma centers over a 5-year period (2017 to 2022) by current procedural terminology (CPT) codes. Current CPT codes for combined femoral shaft and IFNFs were identified to generate our study group. CPT codes for isolated femur fractures were identified to generate a control group. RESULTS: One hundred forty patients comprised our IFNF cohort, and 280 comprised the control cohort. On univariate, there were significant differences in mechanism of injury (P < 0.001), Orthopedic Trauma Association (OTA)/Arbeitsgemeinshaft fur Osteosynthesefragen (AO) classification (P = 0.002), and fracture location (P < 0.001) between cohorts. On multivariate, motor vehicle crashes were more commonly associated with IFNFs compared with other mechanism of injuries. OTA/AO 32A fractures were more commonly associated with IFNFs when compared with OTA/AO 32B fractures (adjusted odds ratio = 0.36, P < 0.001). Fractures through the isthmus were significantly more commonly associated with IFNFs than fractures more proximal (adjusted odds ratio = 2.52, P = 0.011). DISCUSSION: Detecting IFNFs in femoral shaft fractures is challenging. Motor vehicle crashes and motorcycle collisions, OTA/AO type 32A fractures, and isthmus fractures are predictive of IFNFs.


Subject(s)
Femoral Fractures , Femoral Neck Fractures , Orthopedics , Humans , Retrospective Studies , Femoral Neck Fractures/diagnostic imaging , Femoral Neck Fractures/surgery , Femoral Neck Fractures/complications , Femoral Fractures/diagnostic imaging , Femoral Fractures/etiology , Femoral Fractures/surgery , Femur
4.
Arthrosc Sports Med Rehabil ; 6(1): 100857, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38288033

ABSTRACT

Purpose: To assess the utility of using dynamic ultrasound for postoperative evaluation after superior capsular reconstruction (SCR) by evaluating graft integrity and its correlation with clinical outcomes at a minimum 2-year follow-up. Methods: A retrospective chart review was conducted to identify patients who underwent SCR between July 2015 and July 2020 with a minimum 2-year clinical and ultrasound follow-up. Clinical outcome measures included Simple Shoulder (SS) and American Shoulder and Elbow Surgeon (ASES) scores. Integrity of the SCR graft was evaluated by dynamic ultrasound. Results: We evaluated 22 shoulders in 21 patients with a mean follow-up of 44.8 months (range, 24-71 months). The graft was found to be intact by ultrasound evaluation in 82% (18/22). Patients with intact grafts had higher mean SS (11.6 vs 7.8, P = .00079) and ASES (91.2 vs 64.1, P = .0296) scores at latest follow-up compared to those with failed grafts. Those with intact grafts also had significant improvement in SS (3.7 vs 11.6, P < .00001) and ASES (23.2 vs 91.2, P < .00001) scores at latest follow-up compared to their preoperative scores. In contrast, patients with graft failure had no significant improvement in SS (6.3 vs 9.0, P = .123) and ASES (40.4 vs 58.3, P = .05469) scores at latest follow-up compared to their preoperative scores. There was no difference between clinical outcomes at 6 to 12 months vs latest follow-up for both SS (P = .11, P = .5) and ASES (P = .27, P = .21) scores. Conclusions: SCR grafts were found by ultrasound to be intact in 82% of cases. Patients with intact grafts on ultrasound had significant improvement in functional outcome scores while those with graft failure did not. Functional outcome scores suggest that maximal recovery from this procedure occurs by 6 to 12 months. Level of Evidence: Level IV, therapeutic case series.

5.
Arthroscopy ; 40(3): 876-878, 2024 03.
Article in English | MEDLINE | ID: mdl-38219116

ABSTRACT

Arthroscopic access to the posterior root of the medial meniscus is often difficult in a tight medial compartment. To facilitate ease of access, partial lengthening of the medial collateral ligament (MCL) "pie-crusting" has been advocated to increase the working space of the medial compartment during arthroscopy. Purported benefits of MCL include increased visualization and decreased misdiagnosis during diagnostic arthroscopy, decreased iatrogenic chondral injuries with instrumentation, and postoperative medial compartment off-loading. Several techniques of MCL lengthening have been described including percutaneous lengthening, transportal lengthening, and mini-open lengthening. The safety of MCL lengthening has been demonstrated. Patients receiving MCL lengthening have no difference in postoperative laxity, postoperative pain, nor damage to surrounding structures. MCL lengthening also shows improved patient outcome scores and decreased rates of retear of medial meniscal root tear repair.


Subject(s)
Arthroplasty, Replacement, Knee , Knee Injuries , Humans , Menisci, Tibial/surgery , Knee Injuries/surgery , Arthroscopy/methods , Rupture/surgery
6.
JBJS Case Connect ; 13(3)2023 07 01.
Article in English | MEDLINE | ID: mdl-37543730

ABSTRACT

CASE: A 37-year-old man with a right obturator foramen hip dislocation underwent closed reduction under spinal anesthesia with the use of a fracture traction table. CONCLUSION: This novel technique provides surgeons and anesthesiologists an alternative method of treating obturator foramen hip dislocations that provides a more controlled reduction and less need for assistants.


Subject(s)
Anesthesia, Spinal , Fractures, Bone , Hip Dislocation , Male , Humans , Adult , Anesthesia, Spinal/adverse effects , Hip Dislocation/diagnostic imaging , Hip Dislocation/surgery , Hip Dislocation/etiology , Fractures, Bone/complications , Traction/methods
7.
J Orthop Case Rep ; 13(6): 16-19, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37398534

ABSTRACT

Introduction: Acute compartment syndrome (ACS) occurs due to decreased perfusion of an osseofascial space due to increased compartmental pressure. Due to its potentially devastating sequelae, emphasis is placed on its prompt diagnosis. While fractures continue to be the most common cause of ACS, mechanisms such as crush injuries and even surgical positioning are described etiologies of compartment syndrome. ACS of the well-leg from hemilithotomy positioning has been previously depicted in medical literature; however, there have been no illustrations of this complication after elective arthroscopic-assisted posterior cruciate ligament (PCL) reconstruction. Case Report: This report discusses a patient undergoing PCL reconstruction who developed an ACS in the non-operative extremity that was positioned in hemilithotomy in a leg positioner. Conclusion: ACS is an uncommon but serious complication that can occur from hemilithotomy positioning. Surgeons should be mindful of risk factors that can place a patient at higher risk, including length of the case, body habitus, height of elevation of the leg, and method of leg support. The prompt recognition and surgical management of ACS can prevent the devastating long-term complications.

8.
Cureus ; 14(5): e24739, 2022 May.
Article in English | MEDLINE | ID: mdl-35686253

ABSTRACT

Background The increasing use of cardiac implantable electronic devices (CIEDs) in a growing patient population has led to an even greater increase in CIED infection rates. Antibacterial CIED envelopes are often used as part of an infection risk-reduction strategy. However, best practices for when to use an envelope and which envelope to choose remain to be elucidated. Methods In this retrospective study, the records of 455 patients undergoing CIED implantation by a single surgeon were reviewed to identify trends in envelope use and outcomes after implantation through 12 months of follow-up. Of these patients, 165 were managed with a biologic antibacterial CIED envelope (CanGaroo®, Aziyo Biologics, Inc., Silver Spring, MD), 219 with a non-biologic envelope (Tyrx®, Medtronic Inc., Monmouth Junction, NJ), and 71 with no envelope. Results Most patients had two or more infection risk factors (77.9% with any envelope vs. 52.1% with no envelope; P < 0.001). Factors significantly associated with the use of an envelope included the history of heart failure, systemic anticoagulant use, the use of high-power or more complex devices, and reoperations. The overall rate of adverse events was 9.2% (n = 42). Rates of infection and hematoma were 1.8% and 2.6%, respectively. A decision tree is proposed that may aid clinical decision-making when considering CIED envelope usage. Conclusions There were no significant differences between groups in overall or individual adverse event rates. These data provide insight into real-world clinical decisions regarding the use of CIED envelopes and support the use of antibiotic-eluting CIED envelopes to limit infection risk in high-risk patients.

9.
World J Cardiol ; 14(3): 177-186, 2022 Mar 26.
Article in English | MEDLINE | ID: mdl-35432770

ABSTRACT

BACKGROUND: Cardiovascular implantable electronic devices (CIEDs) are implanted in an increasing number of patients each year, which has led to an increase in the risk of CIED infection. Antibacterial CIED envelopes locally deliver antibiotics to the implant site over a short-term period and have been shown to reduce the risk of implant site infection. These envelopes are derived from either biologic or non-biologic materials. There is a paucity of data examining patient risk profiles and outcomes from using these envelope materials in the clinical setting and comparing these results to patients receiving no envelope with their CIED implantation. AIM: To evaluate risk profiles and outcomes of patients who underwent CIED procedures with an antibacterial envelope or no envelope. METHODS: After obtaining Internal Review Board approval, the records of consecutive patients who underwent a CIED implantation procedure by a single physician between March 2017 and December 2019 were retrospectively collected from our hospital. A total of 248 patients within this period were identified and reviewed through 12 mo of follow up. The CIED procedures used either no envelope (n = 57), a biologic envelope (CanGaroo®, Aziyo Biologics) that was pre-hydrated by the physician with vancomycin and gentamicin (n = 89), or a non-biologic envelope (Tyrx™, Medtronic) that was coated with a resorbable polymer containing the drug substances rifampin and minocycline by the manufacturer (n = 102). Patient selection for receiving either no envelope or an envelope (and which envelope to use) was determined by the treating physician. Statistical analyses were performed between the 3 groups (CanGaroo, Tyrx, and no envelope), and also between the No Envelope and Any Envelope groups by an independent, experienced biostatistician. RESULTS: On average, patients who received any envelope (biologic or non-biologic) were younger (70.7 ± 14.0 vs 74.9 ± 10.6, P = 0.017), had a greater number of infection risk factors (81.2% vs 49.1%, P < 0.001), received more high-powered devices (37.2% vs 5.8%, P = 0.004), and were undergoing more reoperative procedures (47.1% vs 0.0%, P < 0.001) than patients who received no envelope. Between the two envelopes, biologic envelopes tended to be used more often in higher risk patients (84.3% vs 78.4%) and reoperative procedures (62.9% vs 33.3%) than non-biologic envelopes. The rate of CIED implant site pocket infection was low (any envelope 0.5% vs no envelope 0.0%) and was statistically equivalent between the two envelope groups. Other reported adverse events (lead dislodgement, lead or pocket revision, device migration or erosion, twiddler's syndrome, and erythema/fever) were low and statistically equivalent between groups (biologic 2.2%, non-biologic 3.9%, no envelope 1.8%). CONCLUSION: CIED infection rates for biologic and non-biologic antibacterial envelopes are similar. Antibacterial envelopes may benefit patients who are higher risk for infection, however additional studies are warranted to confirm this.

11.
Front Cardiovasc Med ; 9: 1006091, 2022.
Article in English | MEDLINE | ID: mdl-36620632

ABSTRACT

Background: Cardiac implantable electronic device (CIED) infection is a potentially serious complication of CIED procedures. Infection risk mitigation includes using guideline-recommended pre-operative intravenous antibacterial prophylaxis (IV ABX). The use of antibiotic-eluting CIED envelopes has also been shown to reduce infection risk. The relationship between and potential benefits associated with guideline-recommended IV ABX in combination with antibacterial envelopes have not been characterized. Methods: Biologic envelopes made from non-crosslinked extracellular matrix (ECM) were implanted into 1,102 patients receiving CIEDs. The implanting physician decided patient selection for using a biologic envelope and envelope hydration solution. Observational data was analyzed on IV ABX utilization rates, antibacterial envelope usage, and infection outcomes. Results: Overall compliance with IV ABX was 96.6%, and most patients received a biologic envelope hydrated in antibiotics (77.1%). After a mean follow-up of 223 days, infection rates were higher for sites using IV ABX <80% of the time vs. sites using ≥80% (5.6% vs. 0.8%, p = 0.008). Physicians demonstrated preference for hydration solutions containing gentamicin in higher-risk patients, which was found by multivariate analysis to be associated with a threefold reduction in infection risk (OR 3.0, 95% CI, 1.0-10.0). Conclusion: These findings suggest that use of antibiotics, particularly gentamicin, in biologic envelope hydration solution may reduce infection risk, and use of antibacterial envelopes without adjunct IV ABX may not be sufficient to reduce CIED infections. Clinical trial registration: [https://clinicaltrials.gov/], identifier [NCT02530970].

12.
Plast Reconstr Surg Glob Open ; 6(8): e1867, 2018 Aug.
Article in English | MEDLINE | ID: mdl-30324055

ABSTRACT

A 46-year-old female presented after 3 years of steadily increasing numbness in her hands bilaterally with worse symptoms in her right hand. She reported nighttime paresthesia and exacerbation of her symptoms while writing, typing, and driving. Tinel's and carpal tunnel compression test were positive bilaterally. During the right hand carpal tunnel release, a layer of synovium was present deep to the carpal ligament with a tendinous portion running midline longitudinally along the median nerve. This layer was an anomalous palmaris profundus (PP) tendon within the carpal tunnel, which inserted distally in the palmar fascia. The PP tendon was freed and released. The PP is a rare muscle variation of the forearm and wrist, and although it has no function, it has been reported as a cause of median nerve compression at the wrist. More commonly, it is an incidental finding during carpal tunnel surgery. Because of its close association with the median nerve, it can cause confusion when encountered during carpal tunnel surgery. Clinicians should be aware of this rare finding, which may be present during carpal tunnel surgery. We present a case, with intraoperative photographs, of a PP tendon that was encountered during a carpal tunnel release.

13.
Future Sci OA ; 3(4): FSO245, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29134129

ABSTRACT

AIM: Carbapenems are antibiotics reserved for treatment of severe infections. Carbapenem antimicrobial susceptibility testing profiles were determined in a population of Klebsiella pneumoniae, and their resistance assessed based on previous and current Clinical and Laboratory Standards Institute criteria. MATERIALS & METHODS: Isolates were examined using an automated antimicrobial susceptibility testing method, and real time polymerase chain reaction to detect the resistance (blaKPC) gene. RESULTS: The prevalence of blaKPC gene was 45/54 (83.3%). Five isolates that were susceptible under the previous criteria changed to nonsusceptible with the current standards. The overall difference in susceptibility between the standards was 8%. CONCLUSION: This study shows that the current Clinical and Laboratory Standards Institute criteria may not offer additional benefits in the fight against carbapenem-resistant Enterobacteriaceae.

14.
S D Med ; 70(10): 467-471, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28957622

ABSTRACT

With the emphasis on pain control (i.e., pain as the fifth vital sign) starting in the late 1990s and the increased prescribing of opioids, the opioid epidemic began. With the expanding misuse of opioids a new emphasis has been given for more responsible management of opioid prescribing by health care providers in all specialties. Since the pain experienced by patients with chronic musculoskeletal pain and acute postoperative pain can be severe, specific attention must be given to these patients who may be at increased risk for opioid abuse. We review the opioid epidemic and the impact of the epidemic on physicians and patients. As a result of this epidemic, several intraoperative techniques have been developed to decrease the need for postoperative pain medication. In addition, we identify several key features of a patient's background and their behavior that can indicate a potential for opioid abuse or misuse. Treatment strategies for providers including opioid prescribing guidelines are also discussed.


Subject(s)
Musculoskeletal Pain/drug therapy , Opioid-Related Disorders/epidemiology , Pain Management , Pain, Postoperative/drug therapy , Analgesics, Opioid/therapeutic use , Chronic Pain/drug therapy , Health Personnel , Humans , Opioid-Related Disorders/prevention & control , Prescription Drug Misuse/prevention & control , Prescription Drug Misuse/statistics & numerical data
15.
Rev. bras. cir ; 83(4): 163-70, jul.-ago. 1993. tab
Article in Portuguese | LILACS | ID: lil-150581

ABSTRACT

Cinquenta episódios de infecçäo bacilar Gram-negativa inclusive episódios de bacteremia, pneumonia, infecçöes da pele e do tecido conjuntivo, infecçöes do trato urinário e infecçöes abdominais - foram tratados com aztreonam. As infecçöes foram curadas em 88 por cento dos pacientes, inclusive todos os nove pacientes com bacteremia e 15 dos 17 pacientes com pneumonia. Trinta por cento das infecçöes foram causadas por Pseudomonas e todas responderam ao tratamento com aztreonam. A baixa incidência de toxicidade e o alto nível de eficácia tornam viável a adoçäo do aztreonam como agente terapêutico único. Quando foram encontrados organismos Gram-positivos ou anaeróbios ou havia suspeitas de sua presença nas infecçöes, a administraçäo adicional de agentes eficazes contra esses organismos foi necessária para a cura


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aztreonam/pharmacology , Bacteremia/drug therapy , Gram-Negative Aerobic Rods and Cocci , Gram-Negative Facultatively Anaerobic Rods/isolation & purification , Urinary Tract Infections/drug therapy , Pneumonia/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...